The long term goals of the Developmental Core are to solicit and provide funding for novel research? projects of HIV research from our three member institutions (FHI, RTI, UNC) as well as our minority partners? (within the UNC system, such as North Carolina Central University, Pembroke, UNC-Greensboro, etc., and? outside, such as the University of Puerto Rico). We shall conduct objective peer review and assign senior? investigators as mentors to nurture the research, publication and grant submission. In the first year of the? new grant cycle we shall combine $150,000 of CFAR funds with $65,000 of UNC funds to support one to two? year small ($5,000-$20,000) awards in all aspects of HIV research (basic and clinical sciences, translational? research, epidemiology, vaccines, and behavioral research). We shall continue to focus on the ongoing? epidemic in women, minorities, and international communities. In addition to our annual RFP, we shall set? aside funds for directed research on emerging problems identified by Core Directors. Outreach and? education will be accomplished through 1) presentation by Awardees at our weekly conference, 2) annual? visits to HMUs on World AIDS Day with didactic talks for students and faculty and solicitation of collaborative? research projects, 3) our annual HIV Update course for 400 clinicians from the Southeast, 4) our annual? World AIDS Day Symposium at UNC for RTI, UNC and FHI, 5) our annual Community Forum reviewing new? information for clients, and 6) a university-wide course on AIDS attended by 250 annually. Promising? minority junior investigators will be identified and mentored until they have successful independent careers.? Continuous quality improvement will remain a focus consisting of a review of the entire process including? solicitation, review, mentoring and productivity of Awardees.? The CFAR Developmental Core has awarded 85 small grants since its inception, of which 11 are still in? progress or in data analysis. Developmental research has resulted in: 55 outside grants, with six more? currently in review; one patent; 64 papers, with 17 more either in press or under review; one free statistical? package available on-line; and 71 presentations at national and international conferences. Developmental? Awardees have already received a total of over $50,000,000 in subsequent funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-11
Application #
7644963
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
11
Fiscal Year
2008
Total Cost
$315,761
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Evon, Donna M; Stewart, Paul W; Amador, Jipcy et al. (2018) A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One 13:e0196908
Gausi, Blessings; Chagomerana, Maganizo B; Tang, Jennifer H et al. (2018) Human Immunodeficiency Virus Serodiscordance and Dual Contraceptive Method Use Among Human Immunodeficiency Virus-infected Men and Women in Lilongwe, Malawi. Sex Transm Dis 45:747-753
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Cheng, Weibin; Xu, Huifang; Zhong, Fei et al. (2018) Can HIV service data be used for surveillance purposes?: a case study in Guangzhou, China. BMC Public Health 18:1268
Gradissimo, Ana; Lam, Jessica; Attonito, John D et al. (2018) Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women. Cancer Epidemiol Biomarkers Prev 27:1407-1415
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Price, Joan T; Mollan, Katie R; Fuseini, Nurain M et al. (2018) Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud 4:21
Davy-Mendez, Thibaut; Napravnik, Sonia; Zakharova, Oksana et al. (2018) Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr 79:510-518
Cole, Stephen R; Edwards, Jessie K; Westreich, Daniel et al. (2018) Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biom J 60:100-114

Showing the most recent 10 out of 1688 publications